Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test
AUTOR(ES)
Wahnschaffe, U
FONTE
BioMed Central
RESUMO
As part of a larger literature study on transgenic animals in mutagenicity testing, test results from the transgenic mutagenicity assays (lacI model; commercially available as the Big Blue® mouse, and the lacZ model; commercially available as the Muta™Mouse), were compared with the results on the same substances in the more traditional mouse bone marrow micronucleus test. 39 substances were found which had been tested in the micronucleus assay and in the above transgenic mouse systems. Although, the transgenic animal mutation assay is not directly comparable with the micronucleus test, because different genetic endpoints are examined: chromosome aberration versus gene mutation, the results for the majority of substances were in agreement. Both test systems, the transgenic mouse assay and the mouse bone marrow micronucleus test, have advantages and they complement each other. However, the transgenic animal assay has some distinct advantages over the micronucleus test: it is not restricted to one target organ and detects systemic as well as local mutagenic effects.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=548135Documentos Relacionados
- Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test
- The bone marrow micronucleus test and metronidazole genotoxicity in different strains of mice (Mus musculus)
- Evaluation of the mutagenic effect of the iodinated contrast medium Urografina® 292 using the micronucleus test in mouse bone marrow cells
- Bone marrow transplantation. Part I--Allogeneic.
- Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.